Inventor · disambiguated record

Yue-Mei Zhang

Also filed as: ZHANG YUE · ZHANG YUE-MEI

50 granted patents·12 pending applications·394 citations·filing 2003–2025

98Inventor score

Technology areasA61P A61K C07K C07D C07C

Files withJANSSEN PHARMACEUTICA NV42 BIAN HAIYAN5 FOG PHARMACEUTICALS INC4 COATS STEVEN J2 CONNOLLY PETER J2

Top patents by PatentIndex Score

62 records

0198US8426401B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted Apr 23, 2013·77 cites·18 claims
0297US11767354B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Sep 26, 2023·3 cites·23 claims
0397US8741887B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Jun 3, 2014·49 cites·4 claims
0497US8697684B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 15, 2014·48 cites·4 claims
0597US8604017B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Dec 10, 2013·49 cites·4 claims
0697US8399454B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted Mar 19, 2013·53 cites·17 claims
0796US10428134B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Oct 1, 2019·7 cites·21 claims
0895US11591379B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 28, 2023·3 cites·20 claims
0994US10968265B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 6, 2021·4 cites·24 claims
1094US10787495B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Sep 29, 2020·3 cites·20 claims
1194US10640544B2Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 5, 2020·4 cites·28 claims
1293US11401315B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Aug 2, 2022·2 cites·24 claims
1393US10858413B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Dec 8, 2020·3 cites·17 claims
1492US8685990B2Pyrimidine compounds as delta opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 1, 2014·19 cites·3 claims
1592US2025026803A1Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
1691US10968264B2Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 6, 2021·2 cites·31 claims
1791US10961293B2Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Mar 30, 2021·2 cites·14 claims
1890US8367653B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Feb 5, 2013·8 cites·19 claims
1989US2024018208A1Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide y receptorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
2088US8362000B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Jan 29, 2013·6 cites·17 claims
2187US8748417B2Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jun 10, 2014·9 cites·2 claims
2286US11230526B1Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jan 25, 2022·2 cites·25 claims
2386US8455476B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted Jun 4, 2013·5 cites·30 claims
2486US2023365644A1Antibody-coupled cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide y receptorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
2585US8362001B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Jan 29, 2013·4 cites·18 claims
2684US8445477B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted May 21, 2013·4 cites·20 claims
2783US8450303B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsBIAN HAIYAN·Filed 2010·Granted May 28, 2013·3 cites·17 claims
2881US8722658B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted May 13, 2014·2 cites·4 claims
2981US8697683B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 15, 2014·2 cites·4 claims
3081US8623858B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Jan 7, 2014·2 cites·4 claims
3180US8962607B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Feb 24, 2015·2 cites·9 claims
3280US8691805B2Azetidinyl diamides as monoacylglycerol lipase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 8, 2014·2 cites·8 claims
3379US11732019B2Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Aug 22, 2023·0 cites·15 claims
3479US9464055B2Quinoline derivatives useful as CB-1 inverse agonistsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 11, 2016·3 cites·16 claims
3579US7803793B2Heterocyclic derived metalloprotease inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Sep 28, 2010·5 cites·32 claims
3678US12134636B2Immunoglobulins and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Nov 5, 2024·0 cites·35 claims
3777US2024117000A1Glucagon like peptide 1 (glp-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereofJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2023·Application pending·0 cites
3875US9266835B2Quinoline derivatives useful as CB-1 inverse agonistsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Feb 23, 2016·2 cites·21 claims
3974US8183371B2Pyrazines as delta opioid receptor modulatorsCONNOLLY PETER J·Filed 2010·Granted May 22, 2012·2 cites·17 claims
4073US10118900B2Benzimidazole derivatives useful as CB-1 inverse agonistsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Nov 6, 2018·1 cites·14 claims
4170US8895573B2Phenoxy-substituted pyrimidines as opioid receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Nov 25, 2014·1 cites·3 claims
4265US11780900B2Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereofJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2019·Granted Oct 10, 2023·0 cites·27 claims
4365US10662170B2Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2018·Granted May 26, 2020·0 cites·2 claims
4464US8575363B2Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitorsZHANG YUE-MEI·Filed 2011·Granted Nov 5, 2013·1 cites·10 claims
4563US10875902B2Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Dec 29, 2020·0 cites·30 claims
4658US10131648B2Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Nov 20, 2018·0 cites·14 claims
4758US2019031618A1Benzimidazole derivatives useful as cb-1 inverse agonistsJANSSEN PHARMACEUTICA NV·Filed 2018·Application pending·0 cites
4854US2023271917A1Amino acidsFOG PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
4953US9790198B2Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetesJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 17, 2017·0 cites·22 claims
5053US2024116985A1Stapled peptides and methods thereofFOG PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites

Showing the top 50 of 62 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Yue-Mei Zhang files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →